$SLDP

Solid Power, Inc.

CIK:0001844862|SEC Filings

Condensed Consolidated Statements of Operations and Comprehensive Income (Loss) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2026	Jun. 30, 2025	Jun. 30, 2026	Jun. 30, 2025
Condensed Consolidated Statements of Operations and Comprehensive Income (Loss)
Revenue	$ (1,017)	$ 6,485	$ 1,088	$ 11,609
Grant income	749	1,055	1,717	1,947
Total revenue and grant income	(268)	7,540	2,805	13,556
Operating Expenses
Direct costs	2,119	8,462	5,667	11,158
Research and development	19,363	18,342	37,111	37,363
Selling, general and administrative	8,539	6,607	16,661	14,934
Total operating expenses	30,021	33,411	59,439	63,455
Operating Loss	(30,289)	(25,871)	(56,634)	(49,899)
Nonoperating Income and Expense
Interest income	4,172	3,237	8,184	6,836
Change in fair value of warrant liabilities	2,250	(3,216)	11,891	2,663
Interest expense	(9)	(7)	(206)	(15)
Other expense	(93)	(151)	(75)	(673)
Total nonoperating income and expense	6,320	(137)	19,794	8,811
Pretax Loss	(23,969)	(26,008)	(36,840)	(41,088)
Income tax expense (income)	(79)	6	5	6
Share of net loss (income) of equity method investee	(69)	(676)	4	(606)
Net Loss Attributable to Common Stockholders	(23,821)	(25,338)	(36,849)	(40,488)
Other Comprehensive Income (Loss)	(552)	13	(1,958)	185
Comprehensive Loss Attributable to Common Stockholders	$ (24,373)	$ (25,325)	$ (38,807)	$ (40,303)
Basic loss per share	$ (0.11)	$ (0.14)	$ (0.17)	$ (0.22)
Diluted loss per share	$ (0.11)	$ (0.14)	$ (0.17)	$ (0.22)
Weighted average shares outstanding - Basic	225,974,899	180,343,931	221,661,211	180,871,314
Weighted average shares outstanding - Diluted	225,974,899	180,343,931	221,661,211	180,871,314

Condensed Consolidated Statements of Cash Flows - USD ($) $ in Thousands	6 Months Ended
	Jun. 30, 2026	Jun. 30, 2025
Cash Flows from Operating Activities
Net loss	$ (36,849)	$ (40,488)
Adjustments to reconcile net loss to net cash and cash equivalents used in operating activities:
Depreciation and amortization	9,491	9,142
Amortization of right-of-use assets	594	741
Loss on sales of property, plant and equipment, net	198	574
Share of net loss (income) of equity method investee	4	(606)
Stock-based compensation expense	5,839	3,983
Change in fair value of warrant liabilities	(11,891)	(2,663)
Accretion of discounts on other long-term liabilities	34	33
Accretion of loan receivable from equity method investee	(70)	(64)
Amortization of premiums and accretion of discounts on available-for-sale securities	(1,510)	(2,490)
Loss on change in assessment of finance lease purchase options		84
Change in operating assets and liabilities that provided (used) cash and cash equivalents:
Accounts receivable	1,374	(2,816)
Contract assets	7,490
Prepaid expenses and other current assets and other assets	2,891	1,729
Accounts payable and other accrued liabilities	(3,508)	(2,054)
Deferred revenue	963	(2,789)
Deferred revenue from related parties	(97)
Accrued compensation	(1,669)	(2,476)
Operating lease liabilities	(457)	(574)
Net cash and cash equivalents used in operating activities	(27,173)	(40,734)
Cash Flows from Investing Activities
Purchases of property, plant and equipment, net	(7,933)	(5,044)
Purchases of available-for-sale securities	(245,450)	(101,690)
Proceeds from sales of available-for-sale securities	163,626	152,453
Gain on sale of available-for-sale securities		3
Cash received on loan receivable from equity method investee	142
Purchases of intangible assets	(4)	(649)
Net cash and cash equivalents (used in) provided by investing activities	(89,619)	45,073
Cash Flows from Financing Activities
Proceeds from exercise of stock options	6	659
Proceeds from issuance of shares of common stock under the ESPP	370	156
Cash paid for withholding of employee taxes related to stock-based compensation	(2,156)	(557)
Repurchase of shares of common stock		(3,592)
Payments on finance lease liabilities	(96)	(170)
Proceeds from the registered direct offering, net of fees	121,345
Net cash and cash equivalents provided by (used in) financing activities	119,469	(3,504)
Net increase in cash and cash equivalents	2,677	835
Cash and cash equivalents at beginning of period	21,607	25,413
Cash and cash equivalents at end of period	24,284	26,248
Supplemental information
Cash paid for interest	206	15
Accrued capital expenditures	2,144	1,092
Unpaid reimbursements on capital expenditures	2,407	417
Accrued withholding of employee taxes related to stock-based compensation	$ 678
Accrued excise tax on stock repurchases		$ 35

Condensed Consolidated Balance Sheets - USD ($) $ in Thousands	Jun. 30, 2026	Dec. 31, 2025
Current Assets
Cash and cash equivalents	$ 24,284	$ 21,607
Marketable securities	218,151	229,177
Accounts receivable	3,187	2,155
Contract assets		7,490
Prepaid expenses and other current assets	5,756	6,998
Total current assets	251,378	267,427
Long-Term Assets
Property, plant and equipment, net	84,207	86,318
Right-of-use operating lease assets, net	6,252	6,727
Investments	177,865	86,997
Intangible assets, net	2,159	2,166
Other assets	880	1,059
Loan receivable from equity method investee	4,327	4,398
Total long-term assets	275,690	187,665
Total assets	527,068	455,092
Current Liabilities
Accounts payable and other accrued liabilities	7,015	8,521
Deferred revenue	1,161	198
Deferred revenue from related parties	75	172
Accrued compensation	6,053	7,043
Operating lease liabilities	913	861
Warrant liabilities	1,990
Total current liabilities	17,207	16,795
Long-Term Liabilities
Warrant liabilities		13,881
Operating lease liabilities	6,621	7,129
Other liabilities	1,091	1,113
Total long-term liabilities	7,712	22,123
Total liabilities	24,919	38,918
Mezzanine Equity
Mezzanine Equity	406	470
Stockholders' Equity
Common Stock, $0.0001 par value; 2,000,000,000 shares authorized; 227,217,240 and 201,181,175 shares issued and outstanding as of June 30, 2026 and December 31, 2025, respectively	23	20
Additional paid-in capital	814,957	690,234
Accumulated deficit	(311,632)	(274,904)
Accumulated other comprehensive income (loss)	(1,605)	354
Total stockholders' equity	501,743	415,704
Total liabilities, mezzanine equity and stockholders' equity	$ 527,068	$ 455,092